View in EDS HTML Full Text PDF Full Text

Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies.

Saved in:
Bibliographic Details
Title: Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies.
Authors: Tao K; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA., Herschhorn A; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Fera D; Department of Chemistry and Biochemistry, Swarthmore College, Swarthmore, PA, USA., Lynch RM; Department of Microbiology, Immunology & Tropical Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC, USA., Julg BD; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA, USA., Korber B; Los Alamos National Laboratory and The New Mexico Consortium, Los Alamos, NM, USA., Shafer RW; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA. rshafer@stanford.edu.
Source: Communications medicine [Commun Med (Lond)] 2026 May 28; Vol. 6 (1). Date of Electronic Publication: 2026 May 28.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42209804
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tao+K%22">Tao K</searchLink>; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Herschhorn+A%22">Herschhorn A</searchLink>; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Fera+D%22">Fera D</searchLink>; Department of Chemistry and Biochemistry, Swarthmore College, Swarthmore, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lynch+RM%22">Lynch RM</searchLink>; Department of Microbiology, Immunology & Tropical Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Julg+BD%22">Julg BD</searchLink>; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Korber+B%22">Korber B</searchLink>; Los Alamos National Laboratory and The New Mexico Consortium, Los Alamos, NM, USA.<br /><searchLink fieldCode="AU" term="%22Shafer+RW%22">Shafer RW</searchLink>; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA. rshafer@stanford.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918250414506676%22">Communications medicine</searchLink> [Commun Med (Lond)] 2026 May 28; Vol. 6 (1). <i>Date of Electronic Publication: </i>2026 May 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Portfolio%22">Nature Portfolio </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9918250414506676 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2730-664X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222730664X%22">2730664X </searchLink><i>NLM ISO Abbreviation: </i>Commun Med (Lond) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42209804
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s43856-026-01680-w
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tao K
      – PersonEntity:
          Name:
            NameFull: Herschhorn A
      – PersonEntity:
          Name:
            NameFull: Fera D
      – PersonEntity:
          Name:
            NameFull: Lynch RM
      – PersonEntity:
          Name:
            NameFull: Julg BD
      – PersonEntity:
          Name:
            NameFull: Korber B
      – PersonEntity:
          Name:
            NameFull: Shafer RW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 05
              Text: 2026 May 28
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2730-664X
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Communications medicine
              Type: main
ResultId 1